General Information
Revision date
2020-02-01
Product name
CANIPLAS CANINE FRESH FROZEN PLASMA
Product Synonyms
None known
1.2.1 Relevant identified uses
Caniplas may aid in the treatment of various conditions in dogs in which the administration of fresh frozen plasma would be considered desirable, e.g severe Pancreatitis, Parvovirus enteritis, Coagulopathies, Hypoproteinaemia, major tissue trauma or surgery, and Disseminated Intravascular Coagulation (DIC)
supplier name
Plasvacc Pty Ltd
Icons in SDS
Company Information
company name
Plasvacc Pty Ltd
Section 2
SECTION 2: Hazards identification
This product is not classified as dangerous goods under the Australian Dangerous Goods Code and is not classified as hazardous according to the classification criteria of NOHSC:1008(2004), Approved Criteria For Classifying Hazardous Substances and the National Code of Practice for the Preparation of Material Safety Data Sheets, 2nd Edition.
Potential health effects
Product has no known adverse health effects. Acute Swallowed Eye Skin Inhaled No adverse health effects expected. None known None known. Chronic None known